Cargando…
Is serine racemase (SRR) a second hit target for LRRK2-G2019S induced Parkinson’s disease?
Autores principales: | Nickels, Sarah Louise, Schwamborn, Jens Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996031/ https://www.ncbi.nlm.nih.gov/pubmed/32985472 http://dx.doi.org/10.4103/1673-5374.293140 |
Ejemplares similares
-
D-Serine metabolism in C6 glioma cells: Involvement of alanine-serine-cysteine transporter (ASCT2) and serine racemase (SRR) but not D-amino acid oxidase (DAO)
por: Sikka, Pilleriin, et al.
Publicado: (2010) -
The Energy Landscape of Human Serine Racemase
por: Raboni, Samanta, et al.
Publicado: (2019) -
An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts
por: Padmanabhan, Shalini, et al.
Publicado: (2020) -
Localization of Serine Racemase and Its Role in the Skin
por: Inoue, Ran, et al.
Publicado: (2014) -
Sociality deficits in serine racemase knockout mice
por: Matveeva, Tatyana M., et al.
Publicado: (2019)